280例肝硬化患者中骨质疏松症发生情况回顾性分析
本文选题:肝硬化 + 骨质疏松症 ; 参考:《吉林大学》2017年硕士论文
【摘要】:背景和目的:骨质疏松症(osteoporosis,OP)是肝硬化患者的骨骼并发症,常无明显症状,如果不及时治疗,会增加骨折风险和影响患者的生活质量。近年来,国外研究表明,肝硬化是OP的危险因素,但肝硬化患者OP发生率报道各不相同,我国肝硬化患者较多,但目前国内关于肝硬化合并OP的发生率研究缺乏大样本数据。本研究旨在通过检测肝硬化患者骨密度(BMD)及25-羟维生素D[25(OH)D]水平,回顾性分析肝硬化患者合并OP的相关情况。方法:本研究终纳入2014年12月-2016年12月在吉林大学第一医院肝病科住院的肝硬化患者280例为研究对象,其中男性168例(60%),女性112例(40%),年龄在34-71岁,平均年龄在55.48±9.06岁。所有患者均采用双能X线吸收法检测腰椎(腰1-4)和股骨颈BMD水平,应用液相色谱-串联质谱法检测血清25(OH)D浓度。选择本院同期年龄、性别相匹配的非肝病住院患者280例为对照组。按照病因将研究对象分为原发性胆汁性肝硬化,即PBC组(40例)和非原发性胆汁性肝硬化组,即非PBC组(240例),其中非PBC组包括:乙肝肝硬化组(HBV组,110例),丙肝肝硬化组(HCV组,80例)、和酒精肝肝硬化组(ALD组,50例)。根据肝硬化严重程度,按照肝功能Child-Pugh分级A、B、C级将研究对象分为对应的A组、B组、C组。分析比较各组间BMD,25(OH)D水平及OP发生情况。结果:1、280例肝硬化患者中,共有61例发生OP,OP发生率21.79%(61/280);正常对照组280例,共有29例发生OP,OP发生率10.36%(29/280),肝硬化组的OP发生率明显高于对照组。肝硬化组腰椎BMD:L1-4,0.757±0.154(g/cm~2),股骨颈0.650±0.147(g/cm~2),分别明显低于正常对照组的0.988±0.145(g/cm~2),0.843±0.153(g/cm~2);肝硬化组25(OH)D水平17.89±12.88 ng/ml,明显低于对照组的28.01±11.89(ng/ml)(p0.001);肝硬化组与对照组BMD及25(OH)D水平均具有统计学差异。2、肝硬化组以Child-Pugh分级分组,将患者分为A、B、C三组。A组、B组、C组腰椎(L1-4)BMD分别为:0.843±0.169(g/cm~2),0.684±0.153(g/cm~2),0.597±0.161(g/cm~2);股骨颈BMD分别为:0.721±0.178(g/cm~2),0.587±0.166(g/cm~2),0.501±0.158(g/cm~2)。从A级到C级,患者BMD呈现下降趋势,且C级BMD水平明显低于A级。A组、B组、C组25(OH)D分别为20.89±11.79(ng/ml),19.24±11.93(ng/ml),12.49±9.21(ng/ml)。从A级到C级,25(OH)D逐渐下降,且C级25(OH)D水平明显低于A级。A-C组分别有11,29,21例发生OP,OP发生率分别为:14.10%,22.31%,29.17%,从A级到C级,OP发生率逐渐上升,C级OP发生率明显高于A级。3、40例PBC患者中,男性4例,女性36例,平均年龄:56.11±11.38岁。17例发生OP,OP发生率为:42.50%(17/40);240例非PBC组中,44例发生OP,OP发生率为18.33%(44/240),PBC组OP发生率显著高于非PBC组(p=0.001)。PBC组BMD:腰椎L1-4,0.505±0.148(g/cm~2),股骨颈0.424±0.132(g/cm~2),分别明显低于非PBC组的BMD:腰椎L1-4为0.799±0.149(g/cm~2)和股骨颈0.688±0.133(g/cm~2)。PBC组25(OH)D浓度为18.99±11.34(ng/ml),低于非PBC组的22.79±12.98(ng/ml),但两者无统计学差异。4、PBC组、HBV组、HCV组、AMD组腰椎(L1-4)BMD分别为:0.505±0.148(g/cm~2)、0.758±0.143(g/cm~2)、0.713±0.151(g/cm~2)、0.653±0.146(g/cm~2);股骨颈BMD分别为:0.424±0.132(g/cm~2)、0.724±0.136(g/cm~2)、0.690±0.157(g/cm~2)、0.613±0.168(g/cm~2),各组年龄差异均无统计学意义。经方差分析及两两比较,PBC组腰椎(L1-4)和股骨颈BMD均分别低于HBV组、HCV组和ALD组;而非PBC组内各组之间BMD均无明显差异(p0.05)。40例PBC患者中,17例发生OP,OP发生率为:42.50%(17/40);110例HBV肝硬化患者中,18例发生OP,发生率为16.36%(18/110);80例HCV肝硬化患者中,13例发生OP,OP发生率为16.25%(13/80);50例ALD患者中,13例发生OP,发生率为26.00%(13/50)。HBV组、HCV组、ALD组组间OP发生率无明显统计学差异;PBC组OP发生率高于其他肝硬化组,并且显著高于HBV组(p=0.001)、HCV组(p=0.002),与ALD组间无统计学差异(p=0.099)。结论:肝硬化患者的25(OH)D及骨密度水平明显降低,且均明显低于同龄非肝硬化对照组,骨质疏松症发生率明显高于对照组。肝硬化患者随着肝功能严重程度加重,骨质疏松发生率呈上升趋势。PBC肝硬化患者较非PBC肝硬化患者更易发生骨质疏松症。
[Abstract]:Background and purpose: Osteoporosis (OP) is a skeletal complication of patients with cirrhosis, which often has no obvious symptoms. If it is not treated in time, it will increase the risk of fracture and affect the quality of life of the patients. In recent years, foreign studies have shown that cirrhosis is a risk factor for OP, but the incidence of OP in patients with cirrhosis is different, and the liver hard in China is hard. There are more patients, but the current domestic study of the incidence of cirrhosis with OP lacks large sample data. This study aims to review the correlation of OP in cirrhosis patients by examining the bone mineral density (BMD) and 25- hydroxyvitamin D[25 (OH) D] levels in cirrhosis patients. Methods: This study was finally included in December -2016 year in Jilin in December 2014. 280 cases of liver cirrhosis hospitalized in the first hospital of the first hospital of the University were studied, including 168 (60%) men (60%), 112 women (40%), age 34-71, and the average age was 55.48 + 9.06 years. All patients were measured by double energy X-ray absorption method and the BMD level of the lumbar vertebra (waist 1-4) and femur neck, and the liquid chromatography tandem mass spectrometry was used to detect the serum 25 (OH) D 280 hospitalized patients with non liver disease matched by the same age in our hospital were selected as the control group. According to the cause, the subjects were divided into primary biliary cirrhosis, namely group PBC (40 cases) and non primary biliary cirrhosis group, that is, non PBC group (240 cases), and non PBC group included hepatitis B cirrhosis group (HBV group, 110 cases), hepatitis C liver cirrhosis group. (group HCV, 80 cases), and alcohol liver cirrhosis group (group ALD, 50 cases). According to the severity of liver cirrhosis, according to the liver function Child-Pugh classification A, B, C, the subjects were divided into A group, B group and C group. The BMD, 25 (OH) D level and occurrence of 1280 cases of liver cirrhosis were compared. 0): 280 cases in the normal control group, 29 cases were OP, and the incidence of OP was 10.36% (29/280). The incidence of OP in the cirrhosis group was significantly higher than that of the control group. The lumbar BMD:L1-4,0.757 + 0.154 (g/cm~2) and the femoral neck 0.650 + 0.147 (g/cm~2) were significantly lower than that of the normal control group, 0.988 + 0.145 (g/cm~2) and 0.843 + (g/cm~2), and the cirrhosis group 25 (OH) D water. The level of 17.89 + 12.88 ng/ml was significantly lower than that of the control group (28.01 + 11.89 (ng/ml)) (p0.001), and the levels of BMD and 25 (OH) D in the cirrhosis group and the control group were all statistically different in.2. The cirrhosis group was divided into Child-Pugh classification groups, and the patients were divided into A, B, C three group, 0.843 + 0.169, 0.684 + 0.153, 0.597 + 0., respectively. 161 (g/cm~2); the femoral neck BMD was 0.721 + 0.178 (g/cm~2), 0.587 + 0.166 (g/cm~2) and 0.501 + 0.158 (g/cm~2). From a to C, the patients' BMD showed a downward trend, and the BMD level of C level was significantly lower than that of class a.A group, B group, 20.89 + 11.79, 19.24 + 11.93, 12.49 +. The level of C 25 (OH) D was significantly lower than that of 11,29,21 in a class a.A-C group, and the occurrence rate of OP was 14.10%, 22.31%, 29.17% respectively. The incidence of OP increased gradually from a to C grade, and the OP incidence of C class was significantly higher than that of class A.3,40 cases, male 4, female 36, and average age: 56.11 + 11.38 years old. Of the 240 non PBC groups, 44 cases had OP, the incidence of OP was 18.33% (44/240), and the incidence of OP in PBC group was significantly higher than that in the non PBC group (p=0.001).PBC group BMD: lumbar L1-4,0.505 0.148 (g/cm~2), and the neck of the femur 0.424 + 0.132 (0.799 + 0.149) and femoral neck 0.688 + 0.133 respectively. The degree was 18.99 + 11.34 (ng/ml), which was lower than that of non PBC group (22.79 + 12.98), but there was no statistical difference between the two groups.4, PBC, HBV, HCV, and AMD group of lumbar vertebrae (L1-4) BMD were 0.505 + 0.148 (g/cm~2), 0.758 + 0.143 (g/cm~2), 0.713 + 0.151, 0.653 + 0.146, respectively. 0.157 (g/cm~2), 0.613 + 0.168 (g/cm~2), the age difference of each group was not statistically significant. After the analysis of variance and 22, the lumbar (L1-4) and the BMD of the femoral neck of group PBC were lower than the HBV group, HCV group and ALD group, while the BMD in non PBC group had no significant difference (P0.05) in the.40 cases, 17 cases were 42.50% (110); 110 The incidence of OP in 18 cases of HBV cirrhosis was 16.36% (18/110). Among 80 patients with HCV cirrhosis, 13 cases were OP, and the incidence of OP was 16.25% (13/80); 13 of the 50 ALD patients were OP (13/50).HBV group, and there was no significant difference between the HCV group and the group of cirrhosis. And significantly higher than group HBV (p=0.001), group HCV (p=0.002), and no statistical difference between group ALD (p=0.099). Conclusion: the level of 25 (OH) D and bone mineral density in patients with liver cirrhosis was significantly lower than that of non cirrhosis control group, and the incidence of osteoporosis was significantly higher than that of the control group. The severity of liver function increased with the severity of liver function in the patients with liver cirrhosis. The incidence of osteoporosis is increasing..PBC patients with cirrhosis are more prone to osteoporosis than non PBC cirrhosis patients.
【学位授予单位】:吉林大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R575.2;R580
【相似文献】
相关期刊论文 前10条
1 吕尤焱,李彤;骨质疏松及其治疗[J];天津体育学院学报;2000年01期
2 关庆义,张智海;甲状旁腺功能亢进致骨质疏松一例报告[J];中华骨科杂志;2000年06期
3 ;焦虑可导致骨质疏松[J];浙江中医杂志;2000年11期
4 施刚,王虹;骨质疏松症的钙疗法[J];国外医药(合成药 生化药 制剂分册);2000年06期
5 武军华;史克-比彻姆公司放弃艾多昔芬对骨质疏松的治疗[J];国外医学.药学分册;2000年01期
6 ;浙江省老年学会骨质疏松委员会学术研讨会在杭召开[J];浙江临床医学;2000年07期
7 吴洁,曹缵孙;骨质疏松症的诊断和治疗新进展[J];国外医学.妇幼保健分册;2000年02期
8 韩祖斌;前言——深入开展骨质疏松症的防治[J];实用老年医学;2000年03期
9 杨涛;骨质疏松症的临床表现[J];中国乡村医生;2000年11期
10 施法兴;骨质疏松症的诊断及其治疗[J];江苏临床医学杂志;2000年01期
相关会议论文 前10条
1 郭晓琴;;浅谈骨质疏松症营养防治的方法[A];中国营养学会第12届全国临床营养学术会议资料汇编[C];2009年
2 陈锦平;;骨质疏松症[A];慢性病健康教育能力培训暨糖尿病教育论坛资料汇编[C];2008年
3 邹小娟;戴红;;中药治疗骨质疏松症的研究概况[A];中华医学会第三次骨质疏松和骨矿盐疾病中青年学术会议论文汇编[C];2011年
4 刘国辉;成德亮;杨述华;;骨质疏松相关因素分析[A];中华医学会第三次骨质疏松和骨矿盐疾病中青年学术会议论文汇编[C];2011年
5 陈瑾瑜;彭永德;游利;;骨质疏松管理模式初探[A];中华医学会第三次骨质疏松和骨矿盐疾病中青年学术会议论文汇编[C];2011年
6 晁爱军;;骨质疏松的经济和社会负担[A];中华医学会第三次骨质疏松和骨矿盐疾病中青年学术会议论文汇编[C];2011年
7 尹大庆;荣国威;吴海宁;赵新华;;骨质疏松门诊女性958例临床分析[A];全国老年骨质疏松专题学术研讨会论文汇编[C];2000年
8 张莹;高治国;王雪萍;;大庆地区社区骨质疏松症的防治[A];全国老年骨质疏松专题学术研讨会论文汇编[C];2000年
9 凌浩进;;中西结合对骨质疏松症诊治与预防的摘要[A];全国老年骨质疏松专题学术研讨会论文汇编[C];2000年
10 喻恒锋;;骨质疏松症几种治疗手段搭配疗效比较[A];全国老年骨质疏松专题学术研讨会论文汇编[C];2000年
相关重要报纸文章 前10条
1 通讯员 应述辉邋涂晓晨 记者 李艳梅;骨质疏松症正成为流行病[N];长江日报;2007年
2 中国骨质疏松基金会秘书长 赵燕玲;骨质疏松一分钟小测试[N];健康时报;2007年
3 主任医师 孙清廉;导致骨质疏松的危险因素[N];上海中医药报;2007年
4 赵靖;补钙+运动 有效预防骨质疏松[N];中国消费者报;2007年
5 记者 于丽珊邋通讯员 霍冉;中医药防治骨质疏松功效受关注[N];中国中医药报;2007年
6 李敏;简单运动治疗骨质疏松[N];中国医药报;2007年
7 牛雨;小心!骨质疏松就在身边[N];医药养生保健报;2007年
8 崔玉艳 佳学;乱吃补钙产品反而易得骨质疏松[N];江苏科技报;2008年
9 记者 张东风;专家呼吁:关注中老年人骨质疏松防治[N];中国中医药报;2008年
10 市一医院骨科 李军;骨质疏松的预防与治疗[N];保定日报;2008年
相关博士学位论文 前10条
1 李忻忆;离子束分析技术对骨质疏松症的研究及在其他领域中的应用[D];复旦大学;2014年
2 安奇君;抑制Evi1基因表达促进BMSCs成骨分化治疗骨质疏松症的研究[D];山西医科大学;2015年
3 周锐;维生素D在成骨细胞骨分化中的分子机制及骨质疏松与动脉钙化相关性的临床研究[D];第三军医大学;2015年
4 孙晓迪;雌激素替代治疗对去势联合废用性骨质疏松的影响[D];山东大学;2015年
5 黄旭;间歇式高频率低载荷机械振动治疗骨质疏松的动物实验研究与短期临床观察[D];吉林大学;2016年
6 姜波;基于数据挖掘的倪康裕老师治疗创伤后废用性骨质疏松症的经验研究[D];浙江中医药大学;2016年
7 司志华;神经肌肉促进术对脑梗死大鼠运动功能、骨质疏松和护骨素的影响[D];山东大学;2016年
8 胡航;孕期咖啡因暴露所致成年子代骨质疏松易感的宫内编程机制[D];武汉大学;2015年
9 罗朵生;调肝启枢化浊法治疗原发性骨质疏松症代谢组学研究[D];广州中医药大学;2016年
10 吴穹;DKK1合成多肽对治疗骨质疏松症和成骨作用的研究[D];南京大学;2011年
相关硕士学位论文 前10条
1 徐鹿鹿;骨密度异常人群骨质疏松症相关知识知晓情况的调查[D];遵义医学院;2015年
2 张燕妮;单中心MHD患者骨质疏松患病情况、危险因素调查及骨折和跌倒风险预测[D];川北医学院;2015年
3 王小华;老年人骨质疏松的影响因素分析[D];河北联合大学;2014年
4 张冲;石家庄市在校女大学生综合骨评价值现况调查及影响因素分析[D];河北医科大学;2015年
5 林葳;成年猪椎体类骨质疏松性生物力学模型的快速建立[D];河北医科大学;2015年
6 王婧;老年慢性心力衰竭患者骨质疏松的临床分析[D];石河子大学;2015年
7 王雪洁;2型糖尿病患者骨质疏松症的影响因素分析及超声诊断的应用价值[D];石河子大学;2015年
8 余光书;补肾健脾方对骨质疏松性髋部骨折术后肌力与骨量的影响[D];福建中医药大学;2015年
9 李明;慢性风湿免疫病儿童骨质疏松症的临床分析暨危险因素探讨[D];北京协和医学院;2015年
10 祁宇轩;磁共振扩散加权成像技术在骨质疏松诊断中的应用价值[D];河北医科大学;2015年
,本文编号:2017577
本文链接:https://www.wllwen.com/yixuelunwen/nfm/2017577.html